2-[1-(trifluoromethyl)cyclopropyl]ethan-1-amine hydrochloride, 95.0%, 5g

2-Chloro-5-methoxybenzaldehyde, 99.0%, 10g

2-(4,4-difluoropiperidin-1-yl)ethan-1-ol hydrochloride, 95.0%, 250mg

6-HYDROXY-3-ISOPROPYL-1H-BENZO[C][1,2,6]THIADIAZIN-4(3H)-ONE 2,2-DIOXIDE, 95%, 25mg

3,5-Diamino-6-bromo-pyrazine-2-carboxylic acid, 95%, 1g

7-CHLORO-3,4-DIHYDRO-ISOQUINOLINE, 95.0%, 5g

Ethyl 4-(1H-imidazol-1-yl)benzoate, 95.0%, 1g

1,2,3,4-TETRAHYDROISOQUINOLIN-5-OL, 95%, 1g

L(-)-Sorbose, min 98 %, pour la biochimie, 100 g, emballage plastique.

Solution de modificateur de matrice de nitrate de palladium, 2 g/L Pd(NO3)2 (99,999 %) dans 1 % HNO3

1-((tert-Butoxycarbonyl)amino)azetidine-3-carboxylic acid, 97%, 250mg

2-((3S,5S,6R)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-((S)-1-(ISOPROPYLSULFONYL)-3-METHYLBUTAN-2-YL)-3-METHYL-2-OXOPIPERIDIN-3-YL)ACETIC ACID, 95%, 50mg

Phosphate dihydrogène de potassium, 1 kg